Vitreous cultures were positive in 42 of 49 (86%) cases. The most frequently cultured organisms were Staphylococcus aureus (13) , Staphylococcus epidermidis (12) , Streptococcus species (8) and Haemophilus inJluenzae (2) Although antifibrosis therapy with 5-fluorouracil (5-FU) and mitomycin C (MMC) was initially reserved for patients with filtration failure or previous surgery, these agents are now being increasingly applied in initial trabeculectomy in adults . With the increased use of antifibrosis agents in filtration surgery, additional concerns have been raised regarding the increased risk of late bleb leaks and endophthalmitis in these eyes. The purpose of this investigation was to describe the risk factors, spectrum of infecting micro-organisms and visual outcomes associated with late-onset BRE at our institution .
Patients and methods
The clinical and laboratory records of all patients with the diagnosis of late-onset BRE who had had intraocular cultures performed at The New York Eye and Ear Infirmary between January 1987 and July 1996 were reviewed. Late-onset BRE was defined as bleb purulence, surrounding conjunctival inflammation and cells in the anterior chamber or vitreous developing at least 1 month after filtering surgery.
Data abstracted from the medical records included age, race, sex, type of surgical procedure, interval from surgery to infection, predisposing risk factors (position of the bleb, presence of an aqueous leak, bleb manipulation, conjunctivitis or blepharitis, contact lens use, ocular trauma) and ocular findings at the time of presentation (lens status, anterior and/ or posterior segment inflammation). Snellen visual acuity and intraocular pressure (lOP) data were recorded for all patients 6 months before diagnosis, at the time of diagnosis, after treatment and 6 months following the infection. Microbiology records were reviewed for all patients. Ocular cultures were considered positive if: (1) there was growth of the same organism on two or more media (chocolate agar, blood agar, anaerobic agar, Sabouraud's dextrose agar or thioglycollate), (2) there was semi-confluent growth on one solid medium, or (3) there was growth at the inoculation site on one medium confirmed by organisms seen on Gram or Giemsa stain.
There was no standard treatment protocol. Treatment consisted of vitreous biopsy or pars plana vitrectomy and intravitreal antibiotics. Additionally, topical or intravitreal steroids and subconjunctival, topical, oral and intravenous antibiotics were administered at the discretion of the treating physician. LogMAR conversions of visual acuity were calculated for statistical correlations. Continuous variables were compared by Student's t-test.
Results
Forty-nine cases of BRE developed in 42 eyes during the course of study. A second episode of endophthalmitis developed in 7 eyes after a quiescent period of at least 3 months. One patient went on to develop a third episode.
The demographic and surgical data are summarised in Table 1 were pseudophakic and 1 of 42 (2%) was aphakic. Risk factors for infection are summarised in Table 2 .
Bleb leaks were documented in 32 of 49 (65%) cases either before or at the time of endophthalmitis diagnosis.
Of the 32 eyes with leaks, an antecedent bleb leak was In 11 of 49 (22%) cases there was a history of bleb manipulation in the 2 weeks prior to the development of the infection (bleb needling, suture lysis or bandage contact lens wear). An episode of mucopurulent conjunctivitis that could be temporally separated from the redness and discharge accompanying the onset of endophthalmitis was present in 4 (8%) cases. There was a contact l ev '5 use; C,. conjunctivitis; T, trauITla; Coag. neg. staph., coagulase-negative staphylococci. V A, visual acuity; lOP, intraocular pressure; -1", six months prior to infection; -2 , at the time of i::nfectio::n; history of refractive contact lens use at the time of development of endophthalmitis in 8 (16%) cases, and blunt trauma 4 days prior to infection in 1 (2%) case.
Intraocular antibiotics were administered in all 49 cases. In 37 of 49 (75%) cases dexamethasone (360 f.Lg) was injected intravitreally. Vitreous cultures were performed in all cases and anterior chamber cultures were performed in 47 of 49 (96%) cases. Vitreous aspiration was performed in 22 of 49 (48%) cases and pars plana vitrectomy was performed in 27 of 49 (55%) cases. In 24 cases vitrectomy was performed as part of the initial procedure while in 3 cases it was performed as a secondary procedure. During the hospitalisation, 8 of 49 (16%) eyes underwent a second surgical procedure (repeat pars plana vitrectomy, 4; pars plana lensectomy, 2; choroidal drainage, 1; reformation of the anterior chamber, 1) after failure of the initial procedure to control the acute infection or to address the sequelae of infection.
Vitreous cultures were positive in 42 of 49 (86%) cases. Staphylococcal species were isolated in 25 of 42 (59%) cases (Staphylococcus aureus, 13; coagulase-negative staphylococci, 12) and streptococcal species were recovered from 8 of 42 (19%) eyes (Streptococcus viridans, 4; Streptococcus pneumoniae, 3; Streptococcus pyogel1es, 1). The remaining isolates included Haemophilus influenzae (2), Acinetobacter (2), Moraxella liquefaciens (1), Moraxella lacunata (1), Neisseria subflava (1), Lactobacillus casci (1) and Serratia marcescens (1) . Bleb surface cultures were obtained in 7 cases. In 5 of 7 (71 %) cultures the same micro-organism was isolated from the intraocular and extraocular cultures.
The mean decrease in 10gMAR acuity after treatment of bleb-related endophthalmitis was 0.77 ± 1.25 (range 0-4.46). The final visual acuity was better than or equal to 20/40 in 10 of 49 (20%) cases, 20/100 in 24 (49%) and 20/400 in 32 (65%) cases. In cases caused by staphylococcal species, 18 of 25 (72%) retained vision better than or equal to 20/400. The mean decrease in 10gMAR vision after infection with coagulase-negative staphylococci was less (0.2) than that with Staphylococcus aureus (1.2). In cases caused by Streptococcus, 2 of 8 (25%) retained vision better than or equal to 20/400. The mean decrease in 10gMAR vision after infection with Streptococcus viridans was greater (2.5) than that with Streptococcus pneul1lolliae and Streptococcus pyogenes (0.9).
There was no statistically significant change in mean lOP before and after BRE (13.7 ± 7.9 mmHg (range 2-43 mmHg) vs 14.4 ± 8.6 mmHg (range 2-43 mmHg)) (p = 0.6). Patients were using a mean of 0.6 ± 1.1 medications (range 0-4) before infection and 1.0 ± 0.9 medications (range 0-3) after infection.
Comment
Late-onset BRE has been reported to occur in 0.2-9.6% of patients following glaucoma filtering surgery.l,2, 4, ll,12,2 1 Infection may occur months to years after filtering surgery, and may result in the loss of useful vision. 1-4, 7, 15,22 With the increased use of adjunctive antifibrotic agents in glaucoma filtration surgery there has been heightened concern about the resultant thin walled blebs, which are thought to be more susceptible to infection than those with thicker walls.1l-13
The microbiological spectrum of organisms isolated in our series differs from that in previous studies. The majority of infections in our patients were due to staphylococcal species, rather than streptococci as previously reported. 5,9,11,12 Staphylococcal species have been reported to be the most commonly isolated organism in acute post-operative endophthalmitis/3-25 particularly following cataract surgery,26 and may be associated with better visual outcomes than streptococci.2 7-2 9 Unlike streptococcal species, staphylococci do not produce exotoxins and do not have the ability to penetrate intact conjunctiva. The high incidence of Staphylococcus-related BRE in our series may be associated with the large number of conjunctival bleb leaks (65% eyes) that may provide direct intraocular access. An alternative hypothesis is that geographic differences may account for the varied spectrum of microbial pathogens observed. Whether conjunctival leaks precede bleb infection or result from it remains speculative. Although our data suggest a strong association between bleb leaks and endophthalmitis, a causal relationship can only be established following a prospective clinical trial.
Visual outcomes following treatment for BRE are generally poor. 1 -5,9,12, 1 3,1 7 ,22 Wolner et al.ll reported visual acuity better than 20/400 in 84% of eyes with late-onset BRE and speculated that early detection, before active vitreous involvement, was a significant factor in their series. Other authors have attributed better visual outcome to lower virulence of infecting organismslO and aggressive, prompt intervention. 3 In our series, 49% of eyes retained 20/100 vision, and 65% retained visual acuity better than or equal to 20/400. These overall outcomes are similar to previous reports. However, if the cases of staphylococcal endophthalmitis are evaluated independently, 18 of 25 (72%) had a final visual acuity of 20/400 or better which is comparable to the visual outcomes after treatment for acute endophthalmitis following cataract extraction caused by coagulase-negative Staphylococcus species.26,29 As previously reported,3 0 we found better visual outcomes among eyes after infection with coagulase-negative Staphylococcus compared with Staphylococcus allreus. Our visual results were less encouraging for Streptococcus species and Haemophilus inJluenzae, in which 3 of 10 (30%) patients had a final visual acuity of 20/400 or better. There are inherent difficulties in attempting to correlate final visual outcome with the infecting microbial pathogen, as other variables may be involved. The amount of pre-existing glaucomatous optic nerve damage, diagnostic delay, antimicrobial resistance and intravitreal inflammatory response may all affect visual outcomes.
In all but 9 cases the lOP did not rise significantly after the resolution of the infection. The lOP remained controlled without any antiglaucomatous medication, or no increase in medication, in 26 of 49 (53%) eyes. As previously reported,l1,12 this suggests that most blebs continue to function after treatment and may remain at risk for repeated infectious episodes.
Filtering bleb leaks were very common in this series. Although some authors have described a high incidence of bleb leaks in eyes with BRE,l1 others have found no such association.S,12 In agreement with previous reports, bleb manipulation, inferior bleb location and the use of contact lenses were also associated with BRE?,S,12,1 4, 19,2 0 Although 86% of our cases had positive vitreous cultures, 43% demonstrated no vitreous cellular reaction at the time of presentation. This suggests that early posterior segment infection may occur in eyes with isolated anterior segment inflammation. In light of these results, we recommend extremely close in-patient or out patient observation in eyes with bleb purulence, a clear vitreous cavity and anterior segment inflammation, and treatment with frequently administered fortified topical antibiotics. If no clinical improvement is observed over the following 24-48 h (e.g. a decrease in the anterior chamber reaction and/ or improvement in visual acuity) or inflammation is detected in the vitreous cavity at any time, vitreous biopsy is recommended with intravitreal antibiotic administration.
In summary, this series is the first to document Staphylococcus species as an important cause of late-onset bleb-related endophthalmitis. Since these pathogens may exhibit less virulence than Streptococcus and Haemophilus species, the potential for visual recovery may be greater.
Visual outcomes associated with coagulase-negative staphylococci are better than with Staphylococcus aureus. It remains unclear, however, whether geographic variability may account for the differences observed in microbial pathogens. Risk factor reduction, education of patients regarding symptoms, early recognition of clinical signs, and appropriate, timely intervention may help to reduce the impact of this sight-threatening complication.
